Pharmacists in Spencer, MA Accepting Medicare

8 Pharmacists found. Showing 1 - 8

Christina Marie Aungst, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 131 Main St, Spencer, MA 01562 Phone: 508-885-3838

Sharmin Porcaro Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 133 Main St, Spencer, MA 01562 Phone: 617-962-6635

Robert Braley, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3 Nottingham Cir, Spencer, MA 01562 Phone: 860-368-8228

Bryanna Pacheco, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 133 Main St, Spencer, MA 01562 Phone: 508-885-3838

Dina Kawmi Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 133 Main St, Spencer, MA 01562 Phone: 508-885-3838

Sarah M Braley, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3 Nottingham Cir, Spencer, MA 01562 Phone: 508-885-7709

Jennifer Altman, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 62 W Main St, Spencer, MA 01562 Phone: 508-885-9073    Fax: 508-885-9278

Jennifer Devlin Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 62 W Main St, Spencer, MA 01562 Phone: 508-885-9073    Fax: 508-885-9278

News Archive

Depomed licensee submits DM-1796 NDA for management of PHN

Depomed, Inc. today announced that its licensee has submitted a New Drug Application (NDA) for DM-1796 to the U.S. Food and Drug Administration (FDA) for the management of postherpetic neuralgia (PHN), or pain after shingles. DM-1796 is an investigational, extended release, once-daily tablet formulation of gabapentin designed to reduce dosing frequency and have a low incidence of side effects.

Despite efforts to improve stroke treatment, delays in emergency transport still prevalent

Despite efforts to close the time gap between symptom onset and stroke treatment - including improvements in public education, 911 dispatch operations, pre-hospital detection and triage, hospital stroke system development, and stroke unit management - a new study presented today at the Society of NeuroInterventional Surgery (SNIS) 12th Annual Meeting suggests that delays in emergency transport are still prevalent and that improvements are needed to ensure patients can be treated within the optimal time window.

First Edition: March 27, 2014

Today's headlines include more coverage of the emerging details of the Obama administration's decision to allow some consumers to enroll in health coverage after the March 31 deadline.

ACE2 receptors for SARS-CoV-2 in human eye

Since its emergence in Wuhan, China, the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has spread rapidly over most of the world's inhabited regions, causing millions of cases and hundreds of thousands of deaths. The primary symptoms of COVID-19, the disease caused by SARS-CoV-2, are fever, dry cough, and tiredness.

Read more Medical News

› Verified 4 days ago